BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis

BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis FREDERICK, MD–(Marketwired – Apr 20, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, over-the-counter pain management devices. The company manufactures and markets its flagship product, ActiPatch® Chronic Musculoskeletal Pain Therapy as a drug-free, wearable […]

BioElectronics’ ActiPatch Exhibits At Australia’s Major Pharmaceutical Event

FREDERICK, MD–(Marketwired – Mar 13, 2017) –  BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced noninvasive bioelectronic pain management medical devices, is pleased to announce that its devices are being featured at the Australian Pharmacy Professional Conference and Trade Exhibition. The conference and trade exhibition is the largest pharmaceutical event in Australia with 232 exhibitors […]

BioElectronics Announces ActiPatch® Available on Amazon

FREDERICK, MD, USA, BioElectronics Corporation (OTC Pink: BIEL), February 9, 2017 8:30 AM, the maker of advanced pain management medical devices, today announced that ActiPatch® Musculoskeletal Pain Therapy device is now available on the US Amazon.com. ActiPatch is the leading nonprescription pain therapy in the United Kingdom with over 300 reviews that rate the device […]

BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy

FREDERICK, MD, USA, February 5, 2017 — BioElectronics Corporation (OTC Pink: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the […]

BioElectronics Company Update: Sept 30, 2016

  • September 30th, 2016
  • News
  • 1 Comment
  • Adam Staelin

Reflexonic, LLC On September 9, 2016, we signed an Exclusive Licensing and Supply Agreement with Reflexonic, LLC. Reflexonic sells and distributes urological medical devices, products, and related medical products. Reflexonic will assist in the development of urological products for the treatment of overactive bladder, interstitial cystitis and bladder pain syndrome by providing device therapeutic specifications, […]

BioElectronics Company Update: August 22, 2016

  • August 22nd, 2016
  • News
  • 0 Comments
  • Adam Staelin

Pending FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. Our […]

Your Voice Matters

  • July 26th, 2016
  • News
  • 0 Comments
  • Adam Staelin

How is your chronic pain treated? If you feel your illness is misunderstood and you could use better or less costly treatments, sign this petition today asking the White House to implement the National Pain Strategy. The National Fibromyalgia & Chronic Pain Association (NFMCPA), with the Consumer Pain Advocacy Task Force (CPATF), recently launched a […]

BioElectronics Company Update – July 22, 2016

  • July 23rd, 2016
  • News
  • 0 Comments
  • Adam Staelin

Pending U.S. FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. […]

BioElectronics Company Update July 7, 2016

  • July 8th, 2016
  • News
  • 0 Comments
  • Adam Staelin

BioElectronics Expands Pulsed Shortwave Technology Thursday, July 7, 2016 Dr. Sree Koneru, our Director of Electroceutical Research working at the Clinical Science and Engineering Research Center, New York State University, Binghamton, New York,  has made significant advances in our understanding and development of pulsed shortwave technology. A series of experiments using a unique testing device […]

BioElectronics Company Update – June 8, 2016

  • June 9th, 2016
  • News
  • 0 Comments
  • Adam Staelin

US FDA Meeting On May 24, 2016, we met with FDA reviewer for our ActiPatch device, key management from the Physical Medicine and Neurotherapeutic Devices Branch, senior leadership from the Division of Neurological and Physical Medicine Devices, and a Regulatory Advisor, Office of Device Evaluation. BioElectronics Attendees: Richard Staelin, PhD, Chairman of Board, PhD in […]